Back to results
US 5,326,905 AGranted
Benzylphosphonic acid tyrosine kinase inhibitors
AssigneePfizer Inc.
InventorsRobert L. Dow, Steven W. Goldstein
Life of this patent
Estimating the term…
Abstract
Certain benzylphosphonic acid compounds, and their pharmaceutically-acceptable salts, are inhibitors of tyrosine kinase enzymes, and so are useful for the control of tyrosine kinase dependent diseases (e.g., cancer, atherosclerosis).
Claims7
A compound of the formula ##STR9## wherein A is, ##STR10## and the pharmaceutically-acceptable cationic salts thereof.
Dependencies are inferred from the claim text.